|
Treace Medical Concepts, Inc. (TMCI) Avaliação DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Treace Medical Concepts, Inc. (TMCI) Bundle
Aprimore suas estratégias de investimento com a calculadora DCF (TMCI)! Revise os conceitos médicos de treace precisos, ajuste as projeções e despesas de crescimento e observe instantaneamente como essas modificações afetam o valor intrínseco de (TMCI).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 57.4 | 94.4 | 141.8 | 187.1 | 209.4 | 292.4 | 408.3 | 570.3 | 796.4 | 1,112.2 |
| Revenue Growth, % | 0 | 64.59 | 50.22 | 31.92 | 11.89 | 39.66 | 39.66 | 39.66 | 39.66 | 39.66 |
| EBITDA | 2.1 | -15.8 | -34.8 | -39.0 | -42.1 | -46.0 | -64.2 | -89.7 | -125.3 | -174.9 |
| EBITDA, % | 3.6 | -16.74 | -24.57 | -20.85 | -20.09 | -15.73 | -15.73 | -15.73 | -15.73 | -15.73 |
| Depreciation | 1.2 | .7 | 4.7 | 5.4 | 8.4 | 7.6 | 10.6 | 14.8 | 20.7 | 28.9 |
| Depreciation, % | 2.11 | 0.72549 | 3.28 | 2.86 | 4.02 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
| EBIT | .9 | -16.5 | -39.5 | -44.4 | -50.5 | -53.6 | -74.8 | -104.5 | -146.0 | -203.9 |
| EBIT, % | 1.49 | -17.47 | -27.85 | -23.71 | -24.12 | -18.33 | -18.33 | -18.33 | -18.33 | -18.33 |
| Total Cash | 18.1 | 105.8 | 81.3 | 123.2 | 75.7 | 170.0 | 237.5 | 331.6 | 463.2 | 646.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 14.5 | 18.6 | 29.2 | 38.1 | 40.8 | 61.6 | 86.0 | 120.1 | 167.8 | 234.3 |
| Account Receivables, % | 25.25 | 19.67 | 20.58 | 20.34 | 19.49 | 21.07 | 21.07 | 21.07 | 21.07 | 21.07 |
| Inventories | 7.8 | 10.6 | 19.3 | 29.2 | 39.3 | 42.6 | 59.5 | 83.1 | 116.0 | 162.0 |
| Inventories, % | 13.63 | 11.19 | 13.63 | 15.63 | 18.75 | 14.56 | 14.56 | 14.56 | 14.56 | 14.56 |
| Accounts Payable | 2.3 | 4.1 | 8.7 | 11.8 | 10.5 | 15.0 | 21.0 | 29.3 | 40.9 | 57.2 |
| Accounts Payable, % | 3.95 | 4.3 | 6.11 | 6.32 | 5.03 | 5.14 | 5.14 | 5.14 | 5.14 | 5.14 |
| Capital Expenditure | -1.1 | -2.7 | -14.8 | -11.5 | -11.6 | -15.7 | -21.9 | -30.6 | -42.8 | -59.7 |
| Capital Expenditure, % | -1.86 | -2.86 | -10.46 | -6.12 | -5.54 | -5.37 | -5.37 | -5.37 | -5.37 | -5.37 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | 1.5 | -19.7 | -43.6 | -44.4 | -50.5 | -53.6 | -74.8 | -104.5 | -146.0 | -203.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -18.4 | -26.8 | -68.6 | -66.1 | -67.7 | -81.3 | -121.5 | -169.7 | -237.0 | -331.0 |
| WACC, % | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 | 7.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -723.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -338 | |||||||||
| Terminal Value | -6,032 | |||||||||
| Present Terminal Value | -4,183 | |||||||||
| Enterprise Value | -4,906 | |||||||||
| Net Debt | 58 | |||||||||
| Equity Value | -4,964 | |||||||||
| Diluted Shares Outstanding, MM | 62 | |||||||||
| Equity Value Per Share | -79.92 |
What You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-filled real TMCI financials.
- Actual Data: Historical data and forward-looking projections (as indicated in the highlighted cells).
- Flexible Forecasting: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect Treace Medical's valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for clarity and user-friendliness, complete with step-by-step guidance.
Key Features
- Customizable Financial Inputs: Adjust essential metrics such as revenue growth, gross margin %, and R&D expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other key financial outputs.
- High-Precision Accuracy: Leverages Treace Medical's actual financial data for credible valuation results.
- Effortless Scenario Analysis: Easily evaluate various assumptions and analyze the resulting impacts.
- Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for Treace Medical Concepts, Inc. (TMCI).
- Step 2: Review the pre-filled financial data and forecasts specific to TMCI.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you modify your assumptions.
- Step 5: Evaluate the outputs and leverage the results for your investment strategies.
Why Choose Treace Medical Concepts, Inc. (TMCI)?
- Precision: Leverage accurate financial data from Treace Medical for reliable insights.
- Adaptability: Tailored for users to easily modify and test various inputs.
- Efficiency: Eliminate the need to construct financial models from the ground up.
- Expert-Level: Crafted with the precision and usability expected at the CFO level.
- Intuitive: User-friendly interface designed for all skill levels, including beginners in financial modeling.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive and trustworthy valuation models for analyzing TMCI's market position.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
- Consultants and Advisors: Deliver precise valuation insights to clients regarding Treace Medical Concepts, Inc. (TMCI).
- Students and Educators: Utilize real-world data for practicing and teaching financial modeling in the healthcare sector.
- Medical Technology Enthusiasts: Gain insights into how companies like Treace Medical Concepts, Inc. (TMCI) are valued in the industry.
What the Template Contains
- Pre-Filled DCF Model: Treace Medical Concepts, Inc.'s (TMCI) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Treace Medical Concepts, Inc.'s (TMCI) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.